Therapy News and Research

RSS

Early stage pancreatic cancer expresses antigen targeted by Immunomedics' PAM4 antibody

Immunomedics has reported in an oral presentation at the 2007 Annual Meeting of the American Association for Cancer Research (AACR) that the antigen targeted by the humanized PAM4 antibody is expressed in early stage pancreatic cancer specimens, a stage before the tumor becomes invasive.

18 Apr 2007

Scientists isolate enzyme that could be used to predict survival for nasopharyngeal cancer

Mayo Clinic Cancer Center scientists, in collaboration with Chinese researchers, have isolated an enzyme that could be used to predict survival and recurrence rates for nasopharyngeal cancer -- a common cancer affecting people from Southeast Asia.

18 Apr 2007

Cell Therapeutics settles law suit with Government

Cell Therapeutics has announced that it has settled all government claims arising out of a Department of Justice investigation into allegations regarding alleged overpayments by Medicare to doctors who prescribed the anti-cancer drug, TRISENOX.

18 Apr 2007

Confidentiality and privacy of personal health information is critical to acceptance of NHIN

"ACP strongly believes in the goal of widespread adoption and use of health information technology to improve quality of care," Michael H. Zaroukian, MD, PhD, FACP, told the National Committee on Vital and Health Statistics subcommittee on Privacy and Confidentiality at their hearing on "Consumer Controls for Sensitive Health Records."

18 Apr 2007

Cell Genesys reports data from clinical trials of GVAX immunotherapy for prostate cancer

Evaluation of antibody responses in patients with advanced prostate cancer from these studies shows that the GVAX cell-based immunotherapy induces antibody responses to a broad array of prostate cancer- associated antigens, including some not previously known to be associated with prostate cancer.

18 Apr 2007

Sensory-deprived brain compensates - increases its plasticity

Whiskers provide a mouse with essential information to negotiate a burrow or detect movement that could signal a predator's presence.

18 Apr 2007

Avalon Pharmaceuticals announces results of AVN944 biomarker study

Avalon Pharmaceuticals has announced the results of an AVN944 biomarker study that utilized Avalon's proprietary AvalonRx technology to identify gene signatures that may be useful for patient stratification.

18 Apr 2007

Antidepressants safe for children and adolescents - black box warnings questioned

Antidepressants are safe and effective for treating anxiety, obsessive compulsive disorder (OCD) and major depressive disorder in children and adolescents, according to a meta-analysis of 27 major studies.

18 Apr 2007

Anemia treatment for patients with kidney disease can differ by dialysis facility type

Large, for-profit dialysis facilities appear to administer higher than necessary amounts of a medication for treating anemia in patients with kidney disease, compared to nonprofit facilities, according to a study in the April 18 issue of JAMA.

18 Apr 2007

Anadys Pharmaceuticals presents data showing ANA773 promotes anti-tumor activity of killer cells

Anadys Pharmaceuticals presented data from an in vitro study showing that the active metabolite of ANA773 promotes natural killer (NK) cell-mediated anti-tumor response by inducing cytokine secretion, cytolysis of tumor cells and enhanced antibody-dependent cellular cytotoxicity (ADCC), during a poster presentation at the Annual Meeting of the American Association of Cancer Research (AACR) in Los Angeles.

18 Apr 2007

Advanced age associated with poorer bladder cancer-specific survival in radical cystectomy patients

Traditional wisdom taught in urological residency has been that healthy octogenarians with bladder cancer may be offered radical cystectomy without a significantly increased incidence of postoperative complications.

18 Apr 2007

Vitamin D: sunshine, diet and supplements - cancer prevention and therapy

Vitamin D deficiency is common and cancer risk is higher among those individuals with low vitamin D levels, according to an analysis of research which will be presented at a symposium by Donald L.

17 Apr 2007

Brain tumor vaccine shows promise

A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.

17 Apr 2007

Thrombogenics announces agreement with Millipore for commercialization of stem cell technology

ThromboGenics NV has announced that it has completed a global license agreement with Millipore Corporation under which ThromboGenics will exclusively license its technology for production of the proprietary stem cell culture medium marketed by Millipore as RESGRO(x).

17 Apr 2007

Selenium as therapy for prostate cancer

Selenium may offer an intervention strategy for the treatment of prostate cancer according to results of a study from the laboratory of Allen Gao, PhD, which will be presented by Yan Hu, PhD, Departments of Medicine and Pharmacology and Therapeutics, Roswell Park Cancer Institute (RPCI) at the 2007 centennial meeting of the American Association for Cancer Research (AACR), April 14-18, in Los Angeles, CA.

17 Apr 2007

Study identifies trends in cerebral aneurysm treatment

Cerebrovascular disease is a leading cause of serious long-term disability, affecting as many as 700,000 people every year.

17 Apr 2007

Predicting cancer risk in the long term

Every day, people make assumptions, educated and not, about their risk for developing cancer.

17 Apr 2007

Natalizumab (Tysabri) reduces vision loss in MS patients

According to a study that appears in the April 17 issue of Neurology, researchers at the University of Pennsylvania School of Medicine have found that natalizumab (TYSABRI), a drug that slows disability and reduces relapse rates in patients with multiple sclerosis (MS), also reduces vision loss in patients with relapsing MS.

17 Apr 2007

Connection between cancer development and Darwinian evolution explored

Cancer is a natural consequence of human evolution. Our genes have not developed to give us long and happy lives.

17 Apr 2007

Most-at-risk nursing home residents to be tested for superbugs

A Johns Hopkins study of adult patients admitted to The Johns Hopkins Hospital showed that patients who resided in nursing homes or other kinds of long-term care facilities at any time within the last six months were far more likely than other adult patients to carry or be infected with a drug-resistant superbug.

17 Apr 2007

Therapy News and Research

Early stage pancreatic cancer expresses antigen targeted by Immunomedics' PAM4 antibody

Scientists isolate enzyme that could be used to predict survival for nasopharyngeal cancer

Cell Therapeutics settles law suit with Government

Confidentiality and privacy of personal health information is critical to acceptance of NHIN

Cell Genesys reports data from clinical trials of GVAX immunotherapy for prostate cancer

Sensory-deprived brain compensates - increases its plasticity

Avalon Pharmaceuticals announces results of AVN944 biomarker study

Antidepressants safe for children and adolescents - black box warnings questioned

Anemia treatment for patients with kidney disease can differ by dialysis facility type

Anadys Pharmaceuticals presents data showing ANA773 promotes anti-tumor activity of killer cells

Advanced age associated with poorer bladder cancer-specific survival in radical cystectomy patients

Vitamin D: sunshine, diet and supplements - cancer prevention and therapy

Brain tumor vaccine shows promise

Thrombogenics announces agreement with Millipore for commercialization of stem cell technology

Selenium as therapy for prostate cancer

Study identifies trends in cerebral aneurysm treatment

Predicting cancer risk in the long term

Natalizumab (Tysabri) reduces vision loss in MS patients

Connection between cancer development and Darwinian evolution explored

Most-at-risk nursing home residents to be tested for superbugs

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News